Aridis Pharmaceuticals In... (ARDS)

AI Score

Unlock

0.00

-0.00 (-100.00%)

At close: Apr 01, 2025, 9:51 AM

Aridis Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017
Cash & Equivalents	35K	19K	1.32M	4.88M	1.89M	6.32M	12.47M	19.99M	18.22M	3.59M	10.47M	8.23M	6.21M	11.81M	16.32M	20.9M	17.33M	8.52M	16.31M	24.24M	34.08M	13.47M	20.39M	25.1M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	9K	50K	332K	518K	960K	980K	n/a	n/a	n/a
Other Long-Term Assets	827K	827K	906K	905K	961K	1.01M	1.02M	1.03M	1.03M	1.06M	1.06M	n/a	1.1M	1.09M	1.08M	557K	2.12M	1.01M	995K	7.37M	41K	345K	345K	345K
Receivables	517K	300K	100K	1.24M	248K	1.59M	395K	237K	1.22M	137K	494K	368K	150K	1.35M	261K	413K	10.6M	2.45M	2.14M	2.1M	800K	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-237K	n/a	n/a	n/a	-368K	-150K	1.54M	1.54M	-413K	n/a	n/a	n/a	-4.11M	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	1.99M	2.17M	2.73M	3.12M	4.49M	3.35M	1.96M	1.98M	1.98M	1.97M	1.54M	1.54M	1.54M	1.54M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	4.11M	3.88M	6.57M	11.63M	8.63M	12.91M	19.77M	26.8M	23.58M	8.94M	15.1M	15.12M	12.11M	16.15M	19.98M	27.97M	31.09M	13.36M	20.51M	24.24M	36.28M	14.43M	21.02M	25.34M
Property-Plant & Equipment	1.58M	1.76M	1.95M	2.15M	2.51M	2.74M	3.01M	1.36M	1.45M	1.37M	1.38M	1.26M	779K	845K	923K	1.01M	1.07M	1.14M	1.19M	1.27M	1.23M	1.28M	1.18M	750K
Goodwill & Intangibles	13K	14K	15K	17K	18K	19K	21K	22K	23K	24K	26K	27K	28K	30K	31K	32K	34K	35K	36K	38K	39K	41K	42K	43K
Total Long-Term Assets	2.42M	2.6M	2.87M	3.07M	3.48M	3.77M	4.05M	2.41M	2.5M	2.45M	2.47M	1.28M	1.91M	1.97M	2.03M	2.13M	3.28M	2.52M	2.74M	7.37M	2.29M	1.67M	1.57M	1.14M
Total Assets	6.53M	6.48M	9.43M	14.7M	12.12M	16.69M	23.82M	26.8M	26.09M	11.39M	17.57M	15.12M	12.11M	18.11M	22.01M	27.97M	34.37M	15.87M	23.25M	31.61M	38.57M	16.1M	22.59M	26.48M
Account Payables	5.41M	6.24M	4.12M	2.31M	4.23M	2.56M	3.03M	5.24M	2.64M	2.46M	3.21M	1.89M	1.22M	1.7M	1.97M	1.75M	3.13M	1.54M	2.72M	2.33M	1.76M	610K	3.5M	933K
Deferred Revenue	380K	380K	19.09M	20.17M	20.39M	20.73M	20.96M	20.84M	19.58M	19.27M	19.31M	18.75M	14.68M	14.66M	14.66M	14.6M	2.54M	n/a	n/a	22K	553K	775K	797K	120K
Short-Term Debt	3.41M	4.73M	2.25M	4.3M	8.63M	n/a	139K	696K	n/a	n/a	605K	439K	356K	277K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	15K	23K	15K	15K	15K	15K	15K	110K	100K	92K	91K	37K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	455K	n/a	n/a	n/a	n/a
Total Current Liabilities	17.48M	20.39M	35.43M	36.9M	42.28M	31.34M	31.01M	33.35M	28.89M	23.68M	24.8M	22.44M	18.12M	18.81M	19.44M	19.33M	8.53M	5.01M	4.54M	5.3M	7.2M	5.07M	6.9M	3.17M
Long-Term Debt	n/a	n/a	n/a	n/a	3.5M	1.56M	1.71M	5.28M	n/a	n/a	110K	276K	359K	438K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	9.36M	8.94M	363K	382K	398K	421K	228K	3K	1K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	8.85M	11.91M	11.87M
Total Long-Term Liabilities	854K	1M	1.89M	2.03M	5.67M	13.28M	13.21M	6.56M	1.35M	1.19M	1.33M	1.36M	5.28M	5.38M	4.94M	5M	17.06M	n/a	n/a	n/a	n/a	8.85M	11.91M	11.87M
Total Liabilities	18.34M	21.4M	37.32M	38.93M	47.94M	44.62M	44.23M	40.91M	30.24M	24.87M	26.12M	23.8M	23.4M	24.19M	24.38M	24.33M	25.59M	5.01M	4.54M	5.3M	7.2M	13.91M	18.8M	15.04M
Total Debt	4.84M	6.29M	3.95M	6.13M	14.08M	13M	12.99M	5.98M	n/a	n/a	715K	715K	715K	715K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	5K	4K	4K	3K	2K	2K	2K	2K	1K	1K	1K	1K	1K	1K	1K	1K	1K	1K	1K	1K	1K	n/a	n/a	n/a
Retained Earnings	-190.42M	-190.34M	-202.48M	-195.67M	-189.28M	-181.04M	-173.06M	-165.29M	-156.49M	-135.48M	-129.99M	-123.1M	-117.28M	-111.49M	-107.27M	-100.77M	-95.12M	-87.53M	-79.15M	-71.09M	-65.65M	-57.73M	-55.78M	-47.63M
Comprehensive Income	7.79M	6.53M	5.91M	5.05M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.07M	-988K	-906K	-823K	-740K	-654K	-572K	-491K	-410K	-337K	-265K	-215K
Shareholders Equity	-11.8M	-14.91M	-27.88M	-24.23M	-35.82M	-27.93M	-20.41M	-14.11M	-4.16M	-13.49M	-8.55M	-8.68M	-11.3M	-6.07M	-2.38M	3.64M	8.78M	10.86M	18.71M	26.31M	31.37M	2.18M	3.79M	11.44M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	9K	50K	332K	518K	960K	980K	n/a	n/a	n/a